Immediate Impact

1 from Science/Nature 70 standout
Sub-graph 1 of 25

Citing Papers

New and emerging treatments for metabolic dysfunction-associated steatohepatitis
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
1 intermediate paper

Works of Mohit Nanda being referenced

Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis.
2004

Author Peers

Author Last Decade Papers Cites
Mohit Nanda 162 104 51 14 274
J. Valverde 68 20 15 12 327
Ali Ghafouri 174 34 87 18 253
G. M. Gulzar 195 33 75 22 304
Ryan Yukimatsu Tanigawa 89 63 122 11 243
Albert Knapp 80 26 28 17 247
Doğan Selçuk 106 17 52 22 320
Lynda Bernsteen 121 19 67 15 331
G Javid 197 22 121 11 306
Tsutomu Karasawa 98 65 40 18 317
Sue Zann Lim 109 41 41 17 314

All Works

Loading papers...

Rankless by CCL
2026